Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma.

Saved in:
Bibliographic Details
Title: Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma.
Authors: Belge Bilgin G; Department of Radiology, Mayo Clinic, Rochester, Minnesota; Belgebilgin.gokce@mayo.edu., Burkett BJ; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Bilgin C; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Durski JM; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Packard AT; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Navin PJ; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Thorpe MP; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Johnson DR; Department of Radiology, Mayo Clinic, Rochester, Minnesota., Johnson G; Department of Radiology, Mayo Clinic, Rochester, Minnesota.; Department of Immunology, Mayo Clinic, Rochester, Minnesota., Halfdanarson TR; Department of Oncology, Mayo Clinic, Rochester, Minnesota; and., Ryder M; Department of Endocrinology, Mayo Clinic, Rochester, Minnesota., Kendi AT; Department of Radiology, Mayo Clinic, Rochester, Minnesota.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 Jan 02; Vol. 67 (1), pp. 96-104. Date of Electronic Publication: 2026 Jan 02.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1535-5667
DOI:10.2967/jnumed.125.270481